Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock 70 kDa protein 1A (Hsp72), encoded by the HSPA1A gene, is a major stress-inducible molecular chaperone belonging to the Hsp70 family. It plays a critical role in maintaining cellular proteostasis by assisting in the folding of newly synthesized polypeptides, refolding misfolded proteins, preventing protein aggregation, and targeting damaged proteins for degradation. Under physiological stress, such as heat shock, oxidative stress, or ischemia, Hsp72 is rapidly upregulated to protect cells from proteotoxic damage and inhibit both caspase-dependent and caspase-independent apoptotic pathways. In oncology, Hsp72 is frequently overexpressed in various cancers, where it promotes tumor cell survival, metastasis, and resistance to chemotherapy and radiotherapy. Conversely, in metabolic and neurodegenerative diseases, a deficiency in Hsp72 expression is associated with insulin resistance and protein aggregation, respectively. Consequently, therapeutic strategies involve either inhibiting Hsp72 in cancer (using small molecules like VER-155008 or covalent inhibitors) or inducing its expression in diabetes and muscular dystrophies (using pharmacological inducers like BGP-15). However, drug development has been challenged by high structural homology with constitutive Hsc70, leading to potential toxicity in normal tissues.
Inhibition of ATPase activity, ATP-competitive inhibition, allosteric inhibition, inhibition of substrate binding, covalent inhibition of lysine residues, pharmacological induction of expression, inhibition of Hsp70 expression, and antibody-dependent cellular cytotoxicity (ADCC) targeting membrane-bound Hsp70.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock 70 kDa protein 1A (Hsp72) (Hsp72).